Stock Expert AI

VanEck Israel ETF (ISRA) ETF Analysis

The VanEck Israel ETF (ISRA) offers investors exposure to Israeli equities, seeking to replicate the BlueStar Israel Global Index. With an AUM of $0.14 billion, ISRA provides a focused approach to investing in Israeli companies.

The ETF's expense ratio is 0.71%. ISRA's top holdings include Teva Pharmaceutical Industries Ltd ADR and major Israeli banks, making it a targeted play on the Israeli economy.

VanEck Israel ETF (ISRA) ETF — Price, Holdings & Analysis

The VanEck Israel ETF (ISRA) offers investors exposure to Israeli equities, seeking to replicate the BlueStar Israel Global Index. With an AUM of $0.14 billion, ISRA provides a focused approach to investing in Israeli companies. The ETF's expense ratio is 0.71%. ISRA's top holdings include Teva Pharmaceutical Industries Ltd ADR and major Israeli banks, making it a targeted play on the Israeli economy.

ETF Overview

VanEck Israel ETF (ISRATM) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the BlueStar Israel Global Index (BLSNTR), which is comprised of equity securities, which may include depositary receipts, of publicly traded companies that are generally considered by the Index Provider to be Israeli companies.
The VanEck Israel ETF (ISRA) aims to mirror the performance of the BlueStar Israel Global Index, providing a concentrated investment in Israeli companies. ISRA's portfolio consists of 81 holdings, offering exposure to various sectors within the Israeli economy. The fund is particularly weighted towards Financial Services, which constitutes 38.5% of the portfolio, followed by Technology at 21.7% and Healthcare at 12.2%. Top holdings include Teva Pharmaceutical Industries Ltd ADR (11.43%), Bank Leumi Le-Israel BM (9.26%), and Bank Hapoalim BM (8.13%). This ETF is designed for investors seeking targeted exposure to the Israeli equity market, offering a way to participate in the growth of Israeli businesses. With over 91% of its holdings based in Israel, ISRA provides a direct investment in the country's economy.

Risk Metrics

ISRA carries a concentration risk due to its focus on a single country, Israel, which accounts for over 91% of its holdings. The fund's sector allocation also presents a risk, with a significant portion of the portfolio concentrated in Financial Services (38.5%) and Technology (21.7%). A downturn in either of these sectors could significantly impact the ETF's performance. The expense ratio of 0.71% is higher than some broad-market equity ETFs, creating a drag on returns, especially in periods of underperformance. ISRA's beta of 1.18 indicates that it is more volatile than the broader market. these may be worth researching factors when evaluating ISRA for their portfolios.

Expense Ratio

0.71%

What does ISRA hold?

HoldingWeight
Teva Pharmaceutical Industries Ltd ADR (TEVA)11.43%
Bank Leumi Le-Israel BM (LUMI.TA)9.26%
Bank Hapoalim BM (POLI.TA)8.13%
Elbit Systems Ltd (ESLT.TA)6.50%
Check Point Software Technologies Ltd (CHKP)3.64%
Israel Discount Bank Ltd Class A (DSCT.TA)3.63%
Mizrahi Tefahot Bank Ltd (MZTF.TA)3.24%
Phoenix Financial Ltd (PHOE.TA)3.18%
Tower Semiconductor Ltd (TSEM.TA)2.69%
Nova Ltd (NVMI)2.26%

How Is the Fund Allocated?

SectorWeight
Financial Services38.5%
Technology21.7%
Healthcare12.2%
Industrials10.8%
Real Estate4.7%
Utilities4.5%
Consumer Cyclical2.0%
Energy2.0%
Communication Services1.9%
Consumer Defensive1.6%
Basic Materials0.2%
CountryWeight
Israel91.1%
United States7.9%
United Kingdom0.4%
Singapore0.3%
Jersey0.2%
Other0.1%

Dividend Yield

0.00%

Risk Metrics

  • Beta: 1.18

Questions & Answers

What is ISRA and what does it track?

The VanEck Israel ETF (ISRA) seeks to replicate the price and yield performance of the BlueStar Israel Global Index. This index is composed of equity securities of publicly traded companies that are generally considered to be Israeli companies.

What is the expense ratio for ISRA?

The expense ratio for the VanEck Israel ETF (ISRA) is 0.71%. This means that for every $10,000 invested in the fund, $71 is used to cover the fund's operating expenses.

While this provides access to a specific market, it is important to consider the cost relative to potential returns.

What are the top holdings in ISRA?

As of 2026-03-15, the top holdings in the VanEck Israel ETF (ISRA) are: Teva Pharmaceutical Industries Ltd ADR, with a weight of 11.43%; Bank Leumi Le-Israel BM, at 9.26%; Bank Hapoalim BM, comprising 8.13%; Elbit Systems Ltd at 6.50%; and…

Check Point Software Technologies Ltd, making up 3.64% of the fund.

Is ISRA a good long-term investment?

Whether ISRA is a suitable long-term investment depends on an individual's investment goals, risk tolerance, and outlook on the Israeli economy. ISRA provides targeted exposure to Israeli equities, which can offer diversification benefits.

However, it also carries concentration risk due to its focus on a single country.

How does ISRA compare to similar ETFs?

ISRA stands out with its specific focus on Israeli equities. While other regional or global ETFs may include some Israeli companies, ISRA offers a more concentrated exposure.

With an expense ratio of 0.71% and AUM of $0.14 billion, ISRA's expense ratio may be higher than broader market ETFs.

Does ISRA pay dividends?

As of 2026-03-15, the VanEck Israel ETF (ISRA) has a dividend yield of 0.00%. This indicates that the fund is not currently distributing dividends to its shareholders.

Investors seeking income-generating investments may need to consider other ETFs with a history of dividend payments. The lack of a dividend yield may be a factor for investors prioritizing current income over capital appreciation.